【电报解读】瑞德西韦药效备受期待，A股上游公司已获得业务询价

七印授权

1MP36N1OME84NYTOAU871VOFOKP7KEPWG8BMKO5PWVNRF9VPC4

2021-03-05 08:11:58

article

0A21BEEDB829FD9DD30CBF59454512F46B50787941AB3AD7C91886FC6F87B02C

zh-CN

FD7ECEC50DE0F3AFA4AC3BC710136BE57B828D65

9241663

02636d79fc7c7cc37b9cb348037eec28743d030e5d570d0d69837a3587bed31880

6a25d9b776196b593c5639d0ae96cb54caf49b1c202e33d6b49881908549e70337b11ffc9a898f7c4de0ac04f635b5c97c18c28b9427392347c17a46af5882c71c

{"parameters":{"adaptation":"sa","commercial":"n"},"type":"cc"}

yuanben_6041e7d6795091.01171254

原本认证

https://www.yuanben.io/article/4017d151-80ef-433a-8cc1-802cc892fada

{"author":"财联社","authorization_pub_key":"0233c6594f619ab2bc6f6d7b56a39f700c2fca37e71ae9483c5d5b750f22bc1bbc"}